Hyperthermy Endocavitary Treatment in Pelvic Pain
Unknown statusPhase 1, Phase 2NCT02837588
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
* Treatment at pelvic floor with hyperactivity with hyperthermy electrode MJS * MJS electrode is effective for transvaginal treatment at pelvic pain patients * Hyperthermy treatment with MJS electrode is more effective to usual drugs treatment
Study details
- Official title
- Endocavitary Radiofrequency Treatment in Patients Who Present With Chronic Pelvic Pain Compared to Usual Drug Therapy
- Conditions
- Interventions
- Device: Hyperthermy treatment with MJS electrode
- Sponsor
- Universidad Rey Juan Carlos
- Collaborators
- Hospital Universitario Virgen de la Victoria
- Start date
- 2015-08
- Primary completion
- 2016-12
- Sex
- Female
- Age range
- from 18 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- Spain
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Women with chronic pelvic pain Exclusion Criteria: * chronic pelvic pain or neurological degenerative etiology * Presence of pathology or infectious processes genitourinary level * possibility of pregnancy or lactating. * Lack of informed consent, mental disorders, dementia, dependent people who need tutor.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02837588